France allows tourists immunised with AstraZeneca's vaccine made by SII


Posted on 17 July 2021


For Illustration Purpose Only.

Starting on Sunday, overseas travellers who have received AstraZeneca's Indian-made vaccines will be allowed to enter France. At the same time, according to a statement released by the Prime Minister on Saturday, France is increasing border inspections to restrict the spread of the delta strain. After a worldwide controversy over the fact that the European Union's COVID-19 certificate only recognises AstraZeneca vaccines created in Europe, the decision to allow tourists immunised with AstraZeneca's vaccine made by India's Serum Institute was made. Several other EU nations have previously agreed to adopt the Indian version, which is popular in the United Kingdom and throughout Africa. The varying restrictions of each country have made this summer's travel season even more challenging. Only vaccines approved by the European Medicines Agency, such as those manufactured by Pfizer/BioNTech, Moderna, Johnson & Johnson, and AstraZeneca, are recognised in France. Starting on Sunday, anyone travelling from the United Kingdom, Spain, Portugal, the Netherlands, Greece, or Cyprus who is not vaccinated will be required to provide a negative test that is less than 24 hours old in order to access French borders. France has reduced the time it takes for a person to be fully vaccinated after the second dosage from two weeks to one week.


Key Points


  • Starting on Sunday, overseas travellers who have received AstraZeneca's Indian-made vaccines will be allowed to enter France.

  • Starting on Sunday, anyone travelling from the United Kingdom, Spain, Portugal, the Netherlands, Greece, or Cyprus who is not vaccinated will be required to provide a negative test that is less than 24 hours old in order to access French borders.


Follow Us On Google Newsstand: Click Here